• Medical_Professionals
• Medical_students
• Nurses

Dear Colleagues,

The International Consensus Conference for Advanced Breast Cancer (ABC) has established itself as a major international breast cancer conference. Its primary aim is the development of international consensus guidelines for the management of ABC patients. These guidelines are based on the most up-to-date evidence and can be used to guide treatment decision making in many different health care settings globally, with the necessary adaptations due to different access to care.

The last meeting, which took place in Lisbon, Portugal in November 2013, brought together over 1000 participants from 71 countries around the world, including health professionals, patient advocates and journalists.

ABC Consensus Conferences have the ambitious goal of improving outcomes for all patients with advanced breast cancer. We believe that health professionals working closely together with patient advocates and with the strong support of media can raise awareness about the needs and challenges faced by this traditionally underserved and forgotten group of patients. We aim to identify research priorities based on the most important areas of unmet need, analyse and discuss available data to provide the most accurate management recommendations, but also to influence policy makers and funding bodies and ultimately improve standards of care, survival and quality of life. Research and education, with accurate usage of available knowledge, throughout the world, are key to achieve these goals.

ABC guidelines are jointly developed by ESO (European School of Oncology) and ESMO (European Society of Medical Oncology) and guidelines or ABC conferences have been endorsed and supported by several other international oncology organizations such as ESGO (European Society of Gynaecological Oncology), EUSOMA (European Society of Breast Cancer Specialists), ESTRO (European Society for Radiotherapy and Oncology), UICC (Union International Contre le Cancer), SIS (Senologic International Society) / ISS (International School of Senology), FLAM (Federacion Latino- Americana de Mastologia), OECI (Organization of European Cancer Institutes), Susan G. Komen and BCRF (Breast Cancer Research Foundation), and discussions are ongoing with several others.

It is therefore with great enthusiasm that we invite you to attend the Advanced Breast Cancer Third International Consensus Conference (ABC3) that will take place in Lisbon, Portugal, on 5-7 November 2015.

We strongly believe that together we will dramatically change the poor outcome of this disease and improve both the quality and length of life of all patients living with ABC worldwide. Through our dedicated efforts over this last decade, we can certainly say to every ABC patient "You are no longer forgotten, but you are still our heroes!"*.

Fatima Cardoso, Eric P. Winer, Larry Norton and Alberto Costa

Conference Chairs

* Metastatic breast cancer patients: The forgotten heroes! The Breast 18: 271-272, 2009

EUR

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Submission Info

Participants are invited to submit abstracts on subjects related to advanced breast cancer, including basic, translational research, clinical issues, nursing and advocacy.

Abstracts will be assessed for presentation at the Conference, either oral or poster, or for publication in the ABC3 Abstract Book, supplement of The Breast.

Best abstracts will be selected for oral presentation within the programme with a 10-minute slide presentation followed by a 5-minute discussion slot.

Best Abstracts oral presentations will be scheduled on Thursday, 5 November and poster presentations  on Friday, 6 November.

Categories: 

Please note that all abstracts should relate to advanced breast cancer:

• Nursing

•

 Patient Advocacy

•

 Basic and translational research

• Clinical issues: Medical oncology

•

 Clinical issues: Radiation oncology

• Clinical issues: Surgical oncology

• Clinical issues: Supportive and palliative care

• Clinical issues: Other topics

Instructions:

• The number of words is limited: 50 words for the title (lower case letters) and about 450 words (maximum 2800 characters) for the body of the abstract.

• Names of research groups should appear in the title, not in the authors’ list.

• Tables and images are not accepted.

• List the authors’ affiliations. The same affiliation should be entered only once.

• The first author will be the corresponding author and the presenter at the Conference.

• The full address with e-mail address of the first author ( = corresponding author and presenter) must be provided. The first author will receive an acknowledgement of receipt and all subsequent communication by e-mail.

• For abstracts accepted for presentation (oral or poster), the first author will be the presenting author and will be requested to register and participate in the Conference.

• It is the responsibility of the first author to ascertain whether all authors are aware of the content of the abstract before submission is made.

The acknowledgement of receipt of the abstract will immediately follow the submission. 

The outcome will be notified by 30 June 2015 to the first author who will be required to register to the Conference (early registration deadline: 31 July 2015).

An exhibition area of 1.500 square meters within the ABC3 venue will be available for exhibitors. The exhibition will be organised on Pavilion 4 and 5, adjacent to the main auditorium. The area will furthermore accommodate the poster sessions, lunches and coffee breaks, and hospitality suites.

The minimum renting surface is 18 sqm for pharmaceutical companies and 9 sqm for publishers and non-profit organisations.

Please note that requests will be dealt with on a first-come/first-served basis.


Rates: